Results 311 to 320 of about 1,395,710 (388)
Involvement of the central nervous system in relapsed T-cell lymphoma: insights from four case studies. [PDF]
Chiriac R, Baseggio L.
europepmc +1 more source
British Journal of Clinical Pharmacology, EarlyView.
Carmelo Rizzari, Stefan Schwartz
wiley +1 more source
Combating cancer immunotherapy resistance: a nano‐medicine perspective
Abstract Cancer immunotherapy offers renewed hope for treating this disease. However, cancer cells possess inherent mechanisms that enable them to circumvent each stage of the immune cycle, thereby evading anti‐cancer immunity and leading to resistance.
Xiangyi Kong+10 more
wiley +1 more source
Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy. [PDF]
Koll L+7 more
europepmc +1 more source
Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor
Abstract Neutrophils are important components of the immune system and play a key role in defending against pathogenic infections and responding to inflammatory cues, including cancer. Their dysregulation indicates potential disease risk factors. However, their functional importance in disease progression has often been underestimated due to their ...
Wenpeng Cai+6 more
wiley +1 more source
Primary Breast Lymphoma: A Rare Presentation of Diffuse Large B-Cell Lymphoma, Germinal Center B-Cell Subtype (DLBCL-GCB). [PDF]
Chrysikos D+7 more
europepmc +1 more source
Pulmonary Intravascular Large B-Cell Lymphoma Diagnosed by Transbronchial Lung Cryobiopsy: A Case Report. [PDF]
Wong YS+4 more
europepmc +1 more source
Abstract Background Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of aggressive non‐Hodgkin's lymphoma with distinct clinical and molecular heterogeneity. DLBCL that arises in extranodal organs is particularly linked to poor prognosis. This study aimed to determine the clinical and molecular characteristics of extranodal involvement (
Si‐Yuan Chen+46 more
wiley +1 more source